By news@appleinsider.com (Andrew Orr) The FDA has approved Dexcom’s G7 wearable for glucose monitoring for people with all types of diabetes, and the company expects it hit pharmacy shelves in 2023.Dexcom G7 works with Apple devicesThe wearable is now cleared in the US for people with all types of diabetes aged two and older. It has a mean absolute relative difference (MARD) of 8.2%, which makes the Dexcom G7 the most accurate continuous glucose monitoring (CGM) system approved by the FDA, according to the company. …

Source:: Apple Insider